Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights

Advanced hepatocellular carcinoma (HCC) management has become more complex as novel therapies have been proven effective. After sorafenib, the approval of other multikinase inhibitors (MKIs) and immune checkpoints inhibitors (ICIs) has considerably increased the number of systemic therapies availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cammarota, Antonella, Zanuso, Valentina, Pressiani, Tiziana, Personeni, Nicola, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482774/
https://www.ncbi.nlm.nih.gov/pubmed/36128575
http://dx.doi.org/10.2147/JHC.S268293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482774/
https://www.ncbi.nlm.nih.gov/pubmed/36128575
http://dx.doi.org/10.2147/JHC.S268293

Ejemplares similares